Endothelial progenitor cells: Characterization, in vitro expansion, and prospects for autologous cell therapy

David M. Smadja; David M. Smadja; Adeline Cornet; Adeline Cornet; Joseph Emmerich; Joseph Emmerich; Martine Aiach; Martine Aiach; Pascale Gaussem; Pascale Gaussem

doi:10.1007/s10565-007-0177-6

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

Immunomodulation by endothelial cells: prospects for cancer therapy

Besa Emini Veseli, Lauren A. Hymel, Khalood Alhosani, Marwa Alhusain, Massimiliano Mazzone, Habiba Alsafar, Peter Carmeliet, Halima Alnaqbi, Lisa M. Becker, Mira Mousa, Fatima Alshamsi, Sarah Kassem Azzam

Chapter in a book2014

Endothelial Progenitor Cells and Cardiovascular Ischemic Diseases: Characterization, Functions, and Potential Clinical Applications

David M. Smadja, Bernard Lévy, Jean‐Sébastien Silvestre

Chapter in a book2019

Endothelial Progenitor Cells and Their Niches

Andreia F. Carvalho, Rui L Reis, Alexandra P. Marques

Article2011

Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia

David M. Smadja, Jean-Paul Duong-Van-Huyen, Liliane Dal Cortivo, Anne Blanchard, Patrick Bruneval, Joseph Emmerich, Pascale Gaussem

Article2007

Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances <i>in vitro</i> angiogenesis with up‐regulation of integrin α<sub>6</sub>

David M. Smadja, David M. Smadja, Ivan Bièche, Ivan Bièche, Dominique Helley, Dominique Helley, Ingrid Laurendeau, Ingrid Laurendeau, Ghislaine Simonin, Ghislaine Simonin, Laurent Muller, Laurent Muller, Martine Aiach, Martine Aiach, Pascale Gaussem, Pascale Gaussem